Found 113 results[ Author] Title Type Year
Filters: First Letter Of Last Name is W [Clear All Filters]
Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study. Contemp Clin Trials, 46, 30-38. presented at the 2016 Jan. doi:10.1016/j.cct.2015.11.009. (2016).
Testing and linkage to HIV care in China: a cluster-randomised trial. Lancet HIV, 4(12), e555-e565. presented at the 2017 12. doi:10.1016/S2352-3018(17)30131-5. (2017).
DSM-5 substance use disorders among adult primary care patients: Results from a multisite study. Drug Alcohol Depend, 179, 42-46. presented at the 2017 10 01. doi:10.1016/j.drugalcdep.2017.05.048. (2017).
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool. Contemp Clin Trials, 50, 90-7. presented at the 2016 09. doi:10.1016/j.cct.2016.07.013. (2016).
Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.. JAMA Intern Med, 174(5), 763-71. presented at the 2014 May. doi:10.1001/jamainternmed.2014.328. (2014).
Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G. Ophthalmology, 124(4), 479-487. presented at the 2017 04. doi:10.1016/j.ophtha.2016.12.004. (2017).
Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra). Oncology (Williston Park), 16(7), 930-1, 935-7. presented at the 2002 Jul.. (2002).
Clinical trials referral resource. Clinical trials of flavopiridol. Oncology (Williston Park), 12(7), 1018, 1023-4. presented at the 1998 Jul.. (1998).
Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341. Oncology (Williston Park), 14(11), 1589-90, 1593-4, 1597. presented at the 2000 Nov.. (2000).
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J Infect Dis, 189(7), 1221-31. presented at the 2004 Apr 01. doi:10.1086/382088. (2004).
Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness. Allergy, 71(11), 1552-1560. presented at the 2016 11. doi:10.1111/all.12895. (2016).
Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials. In Society for Clinical Trials (SCT) 36th Annual Meeting (2015). presented at the 17/05/2015, Arlington, VA. Retrieved from http://www.sctweb.org/public/meetings/2015/home.cfm. (2015).
Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777. Oncology (Williston Park), 13(11), 1527, 1530, 1533. presented at the 1999 Nov.. (1999).
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women. J Infect Dis, 180(4), 1080-8. presented at the 1999 Oct. doi:10.1086/314985. (1999).
Clinical trials referral resource. Clinical trials of dolastatin-10. Oncology (Williston Park), 13(1), 68-70, 75. presented at the 1999 Jan.. (1999).
Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341. Oncology, 14, 1589-15901593-94 1597. presented at the 2000.. (2000).
Clinical trials referral resource. Current clinical trials of bortezomib. Oncology (Williston Park), 17(5), 677-80, 683-6, 691-2. presented at the 2003 May.. (2003).
Immunization with envelope MN rap 120 vaccine in human immunodeficiency virus infected pregnant women. J Infec Dis, 180, 1080-8. presented at the 1999.. (1999).
A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report. Transplant Proc, 37(2), 804-8. presented at the 2005 Mar. doi:10.1016/j.transproceed.2004.12.083. (2005).
A Prospective, Randomized, Multicenter, Double-Blind Study of Early Corticosteroid Cessation Versus Long-Term Maintenance of Corticosteroid Therapy with Tacrolimus and Mycophenolate Mofetil in Primary Renal Transplant Recipients: One Year Report. Transplant Proc, 37, 804-808. presented at the 03/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15848538. (2005).
A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy. Ann Surg, 248, 564-577. presented at the 10/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18936569. (2008).
A Randomized, Double Blind, Placebo Controlled Trial of Early Corticosteroid Cessation vs Chronic Corticosteroid Maintenance Therapy. In American Transplant Congress (ATC). presented at the 21/05/2005, Philadelphia, PA. Retrieved from http://www.prnewswire.com/news-releases/american-transplant-congress-2005-54342612.html. (2005).
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg, 248(4), 564-77. presented at the 2008 Oct. doi:10.1097/SLA.0b013e318187d1da. (2008).
A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy, 68(6), 803-8. presented at the 2013 Jun. doi:10.1111/all.12158. (2013).